Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-10

Clinical Trial Update: Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy [Phase 2]

View source ↗

Summary

This Phase 2 trial assesses pharmacodynamic equivalence of a cardiovascular polypill (AAR: acetylsalicylic acid-atorvastatin-ramipril) versus monotherapy in hyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Ramipril (ramipril)
  • atorvastatin (atorvastatin)

Snippet

Sponsor: Ferrer Internacional S.A. | Conditions: Hypertension | Phase 2 | Status: UNKNOWN